Fibronectin on activated T lymphocytes is bound to gangliosides and is present in detergent insoluble microdomains

Immunology and Cell Biology

Volumn 83, Issue 2, 2005, Pages 167-174

  Blum, Stefan ^a,b   Hug, Friederike ^a   Hänsch, Gertrud M ^a   Wagner, Christof ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b REDCLIFFE HOSPITAL   (Australia)

Author keywords

Detergent insoluble microdomain; Fibronectin; Ganglioside; T lymphocyte

Indexed keywords

ANTIBODY; CD3 ANTIGEN; DETERGENT; FIBRONECTIN; GANGLIOSIDE GM1; ISOPROTEIN;

ALTERNATIVE RNA SPLICING; AMINO TERMINAL SEQUENCE; ARTICLE; BINDING SITE; CELL MEMBRANE; CELL MIGRATION; HUMAN; HUMAN CELL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN PROCESSING; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

BINDING SITES; FIBRONECTINS; GANGLIOSIDES; HUMANS; LYMPHOCYTE ACTIVATION; MEMBRANE MICRODOMAINS; PEPTIDE FRAGMENTS; T-LYMPHOCYTES;

EID: 16344377897     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1711.2005.01318.x     Document Type: Article

References (48)

1. Hynes RO, Yamada KM. Fibronectins. Multifunctional modular glycoproteins. J. Cell Biol. 1982; 95: 369-77.
2. Hynes RO. Distribution of fibronectins in vivo. In: Hynes RO (ed.) Fibronectins. New York: Springer-Verlag, 1990; 24-48.
3. Wagner C, Bürger A, Radsak M, Blum S, Hug F, Hänsch GM. Fibronectin synthesis by activated T lymphocytes: up-regulation of a surface-associated isoform with signalling function. Immunology 2000; 99: 532-9.
4. Wagner C, Pioch M, Meyer C, Iking-Konert C, Andrassy K, Hänsch GM. Differentiation of polymorphonuclear neutrophils in patients with systemic infections and chronic inflammatory diseases: evidence of prolonged life span and de novo synthesis of fibronectin. J. Mol. Med. 2000; 78: 337-45.
5. Kornblihtt AR, Umezawa K, Vibe-Petersen K, Baralle FE. Primary structure of human fibronectin: differential splicing may generate at least 10 polypeptides from a single gene. EMBO J. 1985; 4: 1755-9.
6. Schwarzbauer JE, Patel RS, Fonda D, Hynes RO. Multiple sites of alternative splicing of the rat fibronectin gene transcript. EMBO J. 1987; 6: 2573-80.
7. Magnuson VL, Young M, Schattenberg D et al. The alternative splicing of fibronectin pre-mRNA is altered during aging and response to growth factors. J. Biol. Chem. 1991; 266: 14 654-62.
8. Viedt CD, Bürger A, Hänsch GM. Fibronectin synthesis in tubular epithelial cells: Up-regulation of the EDA splice variant by transforming growth factor β. Kidney Int. 1995; 48: 1810-817.
9. Carnemolla B, Balza E, Siri A et al. A tumor-associated fibronectin isoform generated by alternative splicing of messenger RNA precursors. J. Cell Biol. 1989; 108: 1139-48.
10. Pagani F, Zagato L, Vergani C, Casari C, Sido A, Baralle FE. Tissue-specific splicing pattern of fibronectin messenger mRNA precursor during development and aging in rat. J. Cell Biol. 1991; 113: 1223-9.
11. Hynes RO. Wound healing, inflammation, and fibrosis. In: Hynes RO (ed.). Fibronectins. New York: Springer-Verlag, 1990; 347-64.
12. Pierschbacher MD, Hayman EG, Rouslahti E. Location of the cell-attachment site in fibronectin with monoclonal antibodies and proteolytic fragments of the molecule. Cell 1981; 26: 259-67.
13. Ruoslahti E, Pierschbacher MD. New perspectives in cell adhesion. RGD and integrin. Science 1987; 238: 491-7.
14. Matsuyama JI, Yamada A, Kay J et al. Activation of CD4 cells by fibronectin and anti-CD3 antibody. A synergistic effect mediated by the VLA-5 fibronectin receptor complex. J. Exp. Med. 1989; 169: 1133-40.
15. Wayner EA, Garcia-Pardo A, Humphries MJ, McDonald JA, Carter WG. Identification and characterization of the lymphocyte adhesion receptor for an alternative cell attachment domain (CS-1) in plasma fibronectin. J. Cell Biol. 1989; 109: 1321-30.
16. Davis LS, Oppenheimer-Marks N, Bedarczyk JL, McIntyre BW, Lipsky PE. Fibronectin promotes proliferation of naive and memory T cells by signalling through the VLA-3 and VLA-5 integrin molecules. J. Immunol. 1990; 145: 785-93.
17. Guan JL, Hynes RO. Lymphoid cells recognize an alternative splicing segment of fibronectin via the integrin receptor alpha4beta1. Cell 1990; 60: 53-61.
18. + T cell activation via the CS1 alternatively spliced domain of fibronectin. J. Exp. Med. 1990; 172: 1185-92.
19. Mardon HJ, Gianfranco S. Regulation of alternative splicing in the IIICS region of human fibronectin pre-mRNA encoding cell binding sites CS1 and CS5. J. Cell Sci. 1992; 103: 423-33.
20. Sato T, Tachibana K, Nojima Y, D'Avirro N, Morimoto C. Role of the VLA-4 molecule in T cell costimulation. Identification of the tyrosine phosphorylation pattern induced by the ligation of VLA-4. J. Immunol. 1995; 155: 2938-47.
21. Zardi L, Siri A, Carnemolla B, Santi L, Gardner WD, Hoch SO. Fibronectin: a chromatin-associated protein? Cell 1979; 18: 649-57.
22. Yamada KM, Kennedy DW, Grotendorst GR, Momoi T. Glycolipids: receptors for fibronectin? J. Cell. Physiol. 1981; 109: 343-51.
23. Stamatoglou SC, Keller JM. Interactions of cellular glycosaminoglycans with plasma fibronectin and collagen. Biochem. Biophys. Acta 1982; 719: 90-97.
24. Thompson LK, Horowitz PM, Bentley KL, Thomas DD, Alderete JF, Klebe RJ. Localization of the ganglioside-binding site of fibronectin. J. Biol. Chem. 1986; 261: 5209-14.
25. Saunders S, Bernfield M. Cell surface proteoglycan binds mouse mammary epithelial cells to fibronectin and behaves as a receptor for interstitial matrix. J. Cell Biol. 1988; 106: 423-30.
26. Kornblihtt AR, Vibe-Pedersen K, Baralle FE. Human fibronectin: Molecular cloning evidence for two mRNA species differing by an internal segment coding for structural domain. EMBO J. 1984; 3: 221-6.
27. Yamamoto T, Noble NA, Miller DE, Border WA. Sustained expression of TGF-β1 underlies development of progressive kidney fibrosis. Kidney Int. 1994; 45: 916-27.
28. Ffrench-Constant C, van der Water L, Dvorak HF, Hynes RO. Reappearance of an embryonic pattern of fibronectin splicing during wound healing in the adult rat. J. Cell Biol. 1989; 109: 903-14.
29. Oyama F, Murata Y, Suganuma N, Kimura T, Titani K, Sekiguchi K. Patterns of alternative splicing of fibronectin pre-mRNA in human and fetal tissues. Biochemistry 1989; 28: 1428-34.
30. Nicolo G, Salvi S, Oliver G, Borsi L, Castellani P, Zardi L. Expression of tenascin and of EDB-containing oncofetal fibronectin in human cancer. Cell. Differ. Dev. 1990; 32: 401-408.
31. Montixi C, Langlet C, Bernard A, Thimonier J, Dubois C. Engagement of T cell receptor triggers its recruitment to low density detergent insoluble membrane domains. EMBO J. 1998; 17: 5334-48.
32. Schuck S, Honsho M, Ekroos K, Shevchenko A, Simons K. Resistance of cell membranes to different detergents. Proc. Natl Acad. Sci. USA 2003; 100: 5795-800.
33. Wessel D, Flügge UI. A method for the quantitative recovery of protein in dilutes solution in the presence of detergents and lipids. Anal. Biochem. 1984; 138: 141-3.
34. Sorice M, Parolini I, Sansolini T et al. Evidence for the existence of ganglioside-enriched plasma membrane domains in human peripheral lymphocytes. J. Lipid Res. 1997; 38: 969-80.
35. Hakamori S. Glycoshingolipids in cellular interaction, differentiation and oncogenesis. Annu. Rev. Biochem. 1981; 50: 733-48.
36. Horejsi V. The roles of membrane microdomains (rafts) in T cell activation. Immunol. Rev. 2003; 191: 148-64.
37. Viola A, Schroeder S, Sakakibara Y, Lanzavecchia A. T lymphocyte costimulation mediated by reorganisation of membrane microdomains. Science 1999; 283: 680-82.
38. Davis DM. Assembly of the immunological synapse for T cells and NK cells. Trends Immunol. 2002; 23: 356-63.
39. Horejsi V. Membrane rafts in immunoreceptor signaling: new doubts, new proofs? Trends Immunol. 2002; 23: 562-4.
40. Pizzo P, Giurisato E, Tassi M, Benedetti A, Pozzan T, Viola A. Lipid rafts and T cell receptor signaling: a critical re-evaluation. Eur. J. Immunol. 2002; 32: 3082-91.
41. Schade AE, Levine AD. Lipid raft heterogeneity in human peripheral blood T lymphoblasts: a mechanism for regulating the initiation of TCR signal transduction. J. Immunol. 2002; 168: 2233-9.
42. Pierini LM, Maxfield FR. Flottilas of lipid rafts fore and aft. Proc. Natl Acad. Sci. USA 2001; 17: 9471-3.
43. Morla A, Ruoslahti E. A fibronectin self assembly site involved in fibronectin matrix assembly: reconstruction in a synthetic peptide. J. Cell Biol. 1992; 118: 421-9.
44. Hersey P, Schibeci SD, Townsend P, Burns C, Cheresh DA. Potentiation of lymphocyte responses by monoclonal antibodies to the ganglioside GD3. Cancer Res. 1986; 46: 6083-90.
45. Stout RD, Schwarting GA, Suttles J. Correlation of asialo-GM1 expression with increased total cellular RNA and protein content in normal thymocyte and spleen cell populations. J. Immunol. 1987; 139: 2123-9.
46. Weite K, Miller G, Chapman PB et al. Stimulation of T lymphocyte proliferation by monoclonal antibodies against GD3 ganglioside. J. Immunol. 1987; 138: 1763-71.
47. Boussiotis VA, Pardo NA, Collins H et al. R24 anti-GD3 ganglioside antibody can induce costimulation and prevent induction of alloantigen-specific T cell clonal anergy. Eur. J. Immunol. 1996; 26: 2149-54.
48. Irani DN, Lin KI, Griffin DE. Brain-derived gangliosides regulate the cytokine production and proliferation of activated T cells. J. Immunol. 1996; 157: 4333-40.